Inaktiver Wert

Ardea Biosciences, Inc. Aktie

Aktien

Schlusskurs Nasdaq Andere Börsenplätze
- ^USD	-

SANOFI : AstraZeneca hungry to refill medicine cabinet	30.06.12
SANOFI : GSK goes hostile with $2.6 billion Human Genome offer	09.05.12
Ardea Biosciences, Inc. : Biotech targets fight back as Big Pharma circles	02.05.12
Ardea Biosciences, Inc. : Securities Lawyers at Goldfarb LLP Seeking More Money, Information for Stockholders of Ardea Biosciences, Inc.	01.05.12
Ardea Biosciences, Inc. : Warner Chilcott to explore sale of company	30.04.12

Sektor

	% 1. Jan.	Kap.
VERTEX PHARMACEUTICALS INCORPORATED	+16,45 %	122 Mrd.
REGENERON PHARMACEUTICALS, INC.	+21,96 %	116 Mrd.
ARGENX SE	+23,73 %	27,03 Mrd.
BIONTECH SE	-20,05 %	20,36 Mrd.
BEIGENE, LTD.	-16,28 %	15,91 Mrd.
GENMAB A/S	-16,52 %	16,43 Mrd.
WUXI APPTEC CO., LTD.	-44,35 %	15,6 Mrd.
SAREPTA THERAPEUTICS, INC.	+63,91 %	14,94 Mrd.
NEUROCRINE BIOSCIENCES, INC.	+2,52 %	13,59 Mrd.